Read More Pharma Industry News Eli Lilly completes $2.4bn acquisition of DICE Therapeutics Eli Lilly and Company (Lilly) has finalized its acquisition of DICE Therapeutics, Inc. (NASDAQ: DICE) for $2.4 billion,… byPallavi MadhirajuAugust 10, 2023